Alnylam Pharmaceuticals, Inc. (ALNY)
Alnylam Pharmaceuticals Market Cap : 42.19B for March 6, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Insmed, Inc. | 30.86B |
| Biogen, Inc. | 27.04B |
| Pfizer Inc. | 149.66B |
| Eli Lilly & Co. | 923.07B |
| AbbVie, Inc. | 404.80B |
Market Cap Related Metrics
| PE Ratio | 140.93 |
| PS Ratio | 11.43 |
| Price to Book Value | 53.46 |
| Price to Free Cash Flow | 91.24 |
| Price | 318.10 |
| Earnings Yield | 0.71% |
| Operating PE Ratio | 84.65 |
| Normalized PE Ratio | 127.76 |